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Letter to the Editor 
 
Gordon et al. recently proposed a novel heuristic model for the etiology of perimenopausal 
depression in the Journal (1). The model suggests that ovarian hormone fluctuation during 
menopause transition may cause hypothalamic-pituitary-adrenal (HPA) axis dysregulation, 
which increases interpersonal vulnerability and psychosocial stress sensitivity leading to added 
risk of depression.  
 
Diabetes and it´s precursor, insulin resistance (IR) are associated with depression, but some 
previous results are conflicting regarding differences in the association by age and gender (2). 
Furthermore, it has been suggested that the comorbidity of depression and diabetes might be partly 
explained by shared etiopathogenesis via the HPA axis (3). On the other hand, it has been 
suggested that menopause related loss of ovarian function loss increases IR (4). Consequently, it 
is reasonable to hypothesize that association between depression and IR appears in women 
undergoing menopausal transition. 
  
 
We examined depression symptoms and insulin resistance associations (DIRA) in a prospective 
study setting utilizing the Northern Finland Birth Cohort 1966 (NFBC1966, N=12 231, 
http://www.oulu.fi/nfbc). We compared the DIRA differences between genders at two time 
points, at 31 and 46 years, i.e. before and during the menopausal transition (5).  
 
According to our present findings (Figure 1), DIRA is non-existent in women during reproductive 
age, but emerges during the menopausal transition and is seen statistically significantly in the 
severe depressive symptoms. DIRA is seen at both ages in men, but the association is seen also 
with moderate symptoms at the age of 46 years. 
 
 Our results support the novel model (1) by linking in IR. To our knowledge, this is the first report 
demonstrating the effect of menopause on DIRA. We postulate that the present DIRA shift in 
women stems via the HPA axis (3, 4) triggered by hormonal fluctuations in menopause transition 
(1). The non-existent DIRA among women at 31 years may be explained by the protective effect 
of estradiol on the HPA axis. While fascinating, these findings still leave us observing the 
phenomenon at a distance, since our data does not allow direct pathway scrutiny.   
 
 
 
 
  
References 
 
1. Gordon JL, Girdler SS, Meltzer-Brody SE, Stika CS, Thurston RC, Clark CT, Prairie BA, 
Moses-Kolko E, Joffe H, Wisner KL: Ovarian Hormone Fluctuation, Neurosteroids, and HPA 
Axis Dysregulation in Perimenopausal Depression: A Novel Heuristic Model. Am J Psychiatry 
2015; 172:227-236 
2. Kan C, Silva N, Golden SH, Rajala U, Timonen M, Stahl D, Ismail K. A systematic review and 
meta-analysis of the association between depression and insulin resistance. Diabetes Care 2013; 
36:480-489 
3. Musselman DL, Betan E, Larsen H, Phillips LS. Relationship of depression to diabetes types 1 
and 2: epidemiology, biology, and treatment. Biol Psychiatry 2003;54:317-329 
4. Romero-Aleshire MJ, Diamond-Stanic MK, Hasty AH, Hoyer PB, Brooks HL. Loss of ovarian 
function in the VCD mouse-model of menopause leads to insulin resistance and a rapid 
progression into the metabolic syndrome. Am J Physiol Regul Integr Comp Physiol 2009; 
297:R587-R592 
5. Steiner, AZ. Predicting age at menopause: Hormonal, familial, and menstrual cycle factors to 
consider. Menopausal Med 2011; 12:S1-S5. 
 
 
 
  
FIGURE 1. Associations between insulin resistance and depression (DIRA) in NFBC 1966.a  
 
a The insulin resistance was defined using homeostasis model for insulin resistance (HOMA2-IR), 
and depressive symptoms were quantified by Hopkins Symptom Checklist-25 (HSCL-25); 
depression subscale. Multinomial logistic regression model was used to calculate odds ratios (OR) 
and 95% confidence intervals (95% CI). Subjects in the highest decile of IR were compared with 
the rest. The model was adjusted for education (basic, secondary and tertiary), smoking (never, 
ex-smoker and current smoker), alcohol consumption (grams per day), physical activity 
(frequency of brisk physical activity). The authors were given access to the NFBC 1966 database, 
and these results are based on the data collected at 31 and 46 years (n=5653 and n=5021, 
respectively). 
 
